Business

MOFSL stays bullish on Sun Pharma; sees 16% upside on innovation pipeline

Sun Pharma’s June quarter results met analyst expectations, signaling future growth. The company is expanding its specialty and innovative medicines portfolio significantly.…

Seasonal tailwinds set the stage for select stock rallies

August’s historical seasonality favors Indian equities, with analysts identifying key stocks. Derivatives data reveals fresh long positioning in Delivvery and Aditya Birla…